Dr. Rohan R. Walvekar, MD

Dr. Walvekar practices at Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana, part of Franciscan Missionaries of Our Lady.

Dr. Walvekar's NPI, 1619987997, was assigned on August 9, 2006. Dr. Walvekar holds Louisiana license MD.203050.

Dr. Walvekar's primary practice is Our Lady of the Lake Regional Medical Center, at 5000 Hennessy Blvd, Baton Rouge, LA 70808 in E. Baton Rouge Parish. The practice phone is (225) 765-6565.

Dr. Walvekar's primary practice is Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana, part of Franciscan Missionaries of Our Lady. Dr. Walvekar is also affiliated with University Medical Center New Orleans. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Walvekar to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Walvekar practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Walvekar's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Walvekar's licenses on file in 2 states: Louisiana and Pennsylvania.

CMS data shows 72 Medicare services from Dr. Walvekar across 3 procedure codes in 2024, for 75 Medicare patients. Medicare paid $3,666 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Walvekar in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Walvekar's median patient age at 63, with 59% women.

In 2024, Dr. Walvekar wrote 61 Medicare Part D claims for 31 patients. 98% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $1,038 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Walvekar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 47 papers to Dr. Walvekar, published from 2010 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Endoscopy, Tomography, X-Ray Computed and Salivary Gland Calculi. Dr. Walvekar has published most often in Laryngoscope. Dr. Walvekar's most frequent co-authors are Bridget Catherine Loehn, MD, Daniel Wehrmann Nuss, MD and Celeste Christina Gary, MD.

CMS Open Payments shows 83 general payments to Dr. Walvekar from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Cook Medical LLC paid the most, $61,401.